RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter

May.16
RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter
RELX Technology reported net revenue of RMB 810 million (US $110 million) for Q1 2025, down 0.6% quarter-over-quarter but up 46.5% year-over-year. On a non-GAAP basis, adjusted net profit for the quarter was RMB 250 million (US $34.6 million), a 0.2% decrease from the previous quarter and a 21.0% increase from a year earlier.

On May 16th, RELX Technology (RLX Technology Inc.) (NYSE: RLX) released its unaudited financial report for the first quarter of 2025. According to the report, RELX Technology's net revenue for the first quarter of 2025 was 810 million yuan (110 million US dollars), down 0.6% compared to the previous quarter and up 46.5% year-on-year. Under non-US GAAP, the adjusted net profit for the first quarter was 250 million yuan (34.6 million US dollars), down 0.2% compared to the previous quarter and up 21.0% year-on-year.

 

In the first quarter of 2025, the gross profit was 230 million yuan (31.83 million US dollars) with a gross profit margin of 28.6%, an increase of 2.7% year-on-year. Under non-US GAAP, the adjusted operating profit for the first quarter of 2025 was 110 million yuan (14.58 million US dollars).

 

As of March 31, 2025, RELX Technology had a total of 16.16 billion RMB (2.23 billion USD) in cash and cash equivalents, restricted cash, short-term bank deposits, short-term investments, long-term bank deposits, and long-term investment securities.

 

Founder, Chairman, and CEO of RELX Technology, Wang Ying, stated that:

 

"The international macro environment continues to face complex challenges, with the export amount of China's e-cigarette industry in the first quarter dropping year-on-year. Despite this, we still achieved impressive results. In the near future, under the combined effects of macro environment and regulatory policy changes, the global e-cigarette market will continue to evolve rapidly. As a trusted e-cigarette brand, we have keen market insights, industry-leading product development capabilities, robust inventory management systems, and diversified business layout. The company is confident in seizing growth opportunities in the rapidly changing global market, continuously providing users with high-quality, compliant products, and maintaining a leading position in the industry."

 

RELX Technology CFO Chao Lu said,

 

"Thanks to the efficient implementation of the strategic plan and the expansion of overseas markets, the company continued to achieve year-on-year profit growth in the first quarter of 2025, with net revenue increasing by 46.5% year-on-year to 810 million yuan. Operating profit under non-US GAAP reached 110 million yuan due to effective cost optimization measures. Despite facing challenges such as regulatory changes and market competition in the global market, we are confident that we can drive high-quality business development and increase shareholder value through strong strategic execution."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore Cracks Down on Illegal E-cigarettes Containing Etomidate; Over 100 People Involved in Investigation
Singapore Cracks Down on Illegal E-cigarettes Containing Etomidate; Over 100 People Involved in Investigation
Singapore authorities are stepping up efforts to combat illegal e-cigarettes containing etomidate and other synthetic cannabinoids, with more than 100 individuals currently under investigation. These e-cigarettes, which are infused with the powerful sedative etomidate, pose serious health risks. Authorities have successfully prosecuted the first case involving the manufacture of illegal e-cigarettes containing etomidate, underscoring their tough stance against such offenses.
Aug.15 by 2FIRSTS.ai
Al Fakher Partners with Cannabis Brand Cookies to Launch New Hookah Line Featuring Five Flavors, Including Blueberry Caviar
Al Fakher Partners with Cannabis Brand Cookies to Launch New Hookah Line Featuring Five Flavors, Including Blueberry Caviar
Hookah brand Al Fakher has teamed up with international lifestyle brand Cookies to release a co-branded hookah flavor series, marking Cookies’ first entry into the hookah industry. The collaboration introduces five innovative flavors and officially launched on June 25, 2025, through select retail and online channels.
Aug.18 by 2FIRSTS.ai
Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million
Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million
The WHO Western Pacific Regional Director recently presented the WHO Global Award to Vietnamese Minister of Health Đào Hồng Lan. The tax reforms in the newly revised 2025 Special Consumption Tax Law will enable 2.1 million people in Vietnam to quit or not start smoking by 2031, and will also generate an additional VND24 trillion (US$910 million) in annual state revenue.
Sep.28
Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has expressed concern over Singapore Prime Minister Lawrence Wong’s recent announcement to treat e-cigarettes as a “drug issue” and impose imprisonment penalties. CAPHRA stated that this policy confuses illegal products containing etomidate with legal nicotine devices, goes against harm reduction science, deprives adult smokers of access to safer alternatives, and may instead fuel black market circulation.
Aug.19 by 2FIRSTS.ai
WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher
WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher
The WHO's first global estimate on October 6 showed over 100 million people use e-cigarettes, including at least 15 million adolescents (aged 13–15). The report warned that in reporting countries, children are nine times more likely to vape than adults.
Oct.07 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai